Skip to main content

1 Result(s)

within Shintaro Kurahayashi Remove this filter

and

  1. No Access

    Article

    Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors

    Background Exon 19 deletion and L858R point mutation in exon 21 of the epidermal growth factor receptor (EGFR) are the most commonly encountered mutations in patients with non-small cell lung cancer (NSCLC) and p...

    Taihei Ono, Satoshi Igawa, Shintaro Kurahayashi, Yuriko Okuma… in Investigational New Drugs (2020)